The clinical role of platelet glycoprotein IIb/IIIa receptor inhibitors in ischemic heart disease.
The platelet glycoprotein (GP) IIb/IIIa receptor antagonists are powerful new antiplatelet drugs that show promise in reducing complications of coronary angioplasty and acute coronary syndromes.